← Research hub  ·  securities

TRTY · Cambria Trinity ETF $31.91 -0.16 (-0.50%) 2026-SEP-18 12:26 EST

My allocationNot heldas of 2026-SEP-03 · allocation page ↗
Research: QT · SA · STK1 mention
2026-AUG-19 · Meb Faber · The Meb Faber Show / Cambria webinar recording · Positiveinsight · ▶ 35:23 · source page ↗$31.77

In short: Half buy-and-hold global allocation, half trend — "those two come together and form sort of the perfect all-in allocation for me." Cambria's largest allocation ETF and, in his words, "what I do with most of my money."

In plain English

TRTY is a one-ticket portfolio that blends two opposite philosophies in equal halves. One half is a plain buy-and-hold global allocation across stocks, bonds and real assets — you own everything and sit still. The other half is trend following: it only holds what is currently going up, and when markets roll over it sells and can sit almost entirely in cash and bonds. The idea is that the buy-and-hold half keeps you invested through the years when trend gets whipsawed, and the trend half gets you out of the way of a genuine bear market.

The disclosure that carries the most weight here isn't a performance number: it's Cambria's largest allocation fund, and Faber says plainly that TRTY is "what I do with most of my money." Whether that reassures you or simply tells you the manager is his own biggest customer is the reader's call — but he did put it on the record.

35:23A lot of people are not trend following investors or don't use that allocation. To me, those two come together and form sort of the perfect all-in allocation for me, which is called Trinity, TRTY, which I think is our largest allocation ETF, and it's what I do with most of my money.

SOD $31.77

Nothing matches this filter.

Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.